Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The authors reply.
Kim-Mitsuyama S, Ogawa H, Matsui K, Jinnouchi T, Jinnouchi H, Arakawa K. Kim-Mitsuyama S, et al. Among authors: jinnouchi t, jinnouchi h. Kidney Int. 2013 Nov;84(5):1047-8. doi: 10.1038/ki.2013.313. Kidney Int. 2013. PMID: 24172735 Free PMC article. No abstract available.
Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H, Kim-Mitsuyama S, Jinnouchi T, Matsui K, Arakawa K. Ogawa H, et al. Among authors: jinnouchi t. Hypertens Res. 2009 Jul;32(7):575-80. doi: 10.1038/hr.2009.60. Epub 2009 May 15. Hypertens Res. 2009. PMID: 19444280 Clinical Trial.
An angiotensin II receptor blocker-calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone.
Kim-Mitsuyama S, Ogawa H, Matsui K, Jinnouchi T, Jinnouchi H, Arakawa K. Kim-Mitsuyama S, et al. Among authors: jinnouchi t, jinnouchi h. Kidney Int. 2013 Jan;83(1):167-76. doi: 10.1038/ki.2012.326. Epub 2012 Oct 10. Kidney Int. 2013. PMID: 23051740 Free PMC article. Clinical Trial.
The authors reply.
Kim-Mitsuyama S, Ogawa H, Matsui K, Jinnouchi T, Jinnouchi H, Arakawa K. Kim-Mitsuyama S, et al. Among authors: jinnouchi t, jinnouchi h. Kidney Int. 2013 Jul;84(1):215-6. doi: 10.1038/ki.2013.127. Kidney Int. 2013. PMID: 23812367 Free article. No abstract available.
Sex differences in response to angiotensin II receptor blocker-based therapy in elderly, high-risk, hypertensive Japanese patients: a subanalysis of the OSCAR study.
Matsui K, Kim-Mitsuyama S, Ogawa H, Jinnouchi T, Jinnouchi H, Arakawa K; OlmeSartan Calcium Antagonists Randomized (OSCAR) Study Group. Matsui K, et al. Among authors: jinnouchi t, jinnouchi h. Hypertens Res. 2014 Jun;37(6):526-32. doi: 10.1038/hr.2014.23. Epub 2014 Mar 6. Hypertens Res. 2014. PMID: 24599010 Clinical Trial.
A pilot study of ezetimibe vs. atorvastatin for improving peripheral microvascular endothelial function in stable patients with type 2 diabetes mellitus.
Sugiyama S, Jinnouchi H, Hieshima K, Kurinami N, Suzuki T, Miyamoto F, Kajiwara K, Matsui K, Jinnouchi T. Sugiyama S, et al. Among authors: jinnouchi t, jinnouchi h. Lipids Health Dis. 2015 Apr 23;14:37. doi: 10.1186/s12944-015-0028-z. Lipids Health Dis. 2015. PMID: 25903215 Free PMC article. Clinical Trial.
Liraglutide, a glucagon-like peptide-1 analog, increased insulin sensitivity assessed by hyperinsulinemic-euglycemic clamp examination in patients with uncontrolled type 2 diabetes mellitus.
Jinnouchi H, Sugiyama S, Yoshida A, Hieshima K, Kurinami N, Suzuki T, Miyamoto F, Kajiwara K, Matsui K, Jinnouchi T. Jinnouchi H, et al. Among authors: jinnouchi t. J Diabetes Res. 2015;2015:706416. doi: 10.1155/2015/706416. Epub 2015 Apr 2. J Diabetes Res. 2015. PMID: 25922845 Free PMC article.
72 results